Upadacitinib and its role in the treatment of vitiligo: A new possible therapeutic perspective

類似資料

• Topical 1.5% ruxolitinib cream for facial refractory segmental vitiligo: A retrospective single-center study
  著者:: Hequn Huang, MM, 等
  出版事項: (2026-02-01)
• Serum calprotectin in nonsegmental vitiligo: a possible marker of disease activity
  著者:: Dalia A. Bassiouny, 等
  出版事項: (2025-01-01)
• Bimatoprost, Microneedling, and Tacrolimus Versus Tacrolimus Alone in the Treatment of Stable Nonsegmental Vitiligo: A Pilot Split Study
  著者:: Amr Mohamed Zaky, 等
  出版事項: (2024-02-01)
• Upadacitinib and its role in the treatment of vitiligo: A new possible therapeutic perspective
  著者:: Jorge Magdaleno-Tapial, PhD, 等
  出版事項: (2024-04-01)
• Serum levels of macrophage migration inhibitory factor and interleukin 17 in patients with nonsegmental vitiligo
  著者:: Osama S Sorour, 等
  出版事項: (2020-01-01)